Welcome to

Ron’s COVID-19 Page

What’s new on this site

See our new Variants page, which is intended as a primer to promote understanding of the dizzying array of new variants which the pandemic is creating at an accelerating rate. The other charts on this site have been significantly pared down to those for which credible and reasonably timely pandemic-related statistics are still available. We have reluctantly dropped all international comparisons because the quality and availability of the data are now simply too poor.

Who We Are

This site shares the results of an ongoing personal project to better understand why the pandemic has developed in such a damaging way in Canada, what other jurisdictions have done to better protect their citizens from those impacts and what we can collectively do to reduce the carnage of the unnecessary third wave which is now upon us.  It neither represents nor receives funding from any other person or organization.  The sole purpose is to provide the latest and most meaningful data and insights related to the pandemic and its impact on our society in a readily accessible format.  You will find many meaningful charts and analyses which provide context for the statistics summarized in the above table by clicking on the Global, Canada, Ontario and Kingston menus. For more details, see the About page. 

Weekly Pandemic Update

June 1 to 8

The most-recently available official statistics confirm that the unexpected spring rebound in new COVID infections has leveled off at higher infection rates than last year at the same time. 

The overall Ontario most recent two-week estimate for COVID viral counts in Ontario municipal wastewater PCR test results shows a moderate decline. Likewise, actual human PCR test results stopped rising in the last week of May, as did COVID-related hospitalizations and ICU admissions. 

The more independent COVID-19 Resources Canada Hazard Index has not been updated in the past week. It had estimated one in 68 Ontarians undergoing COVID bouts and therefore being infectious. 

This week’s bar chart of the relative ‘market shares’ of the COVID variants currently afflicting our US neighbours is no longer entirely drawn in shades of blue. The red slice depicts XDV.1, a new, very different “recombinant” strain based on the long-dormant BA.2 family of Omicron variants. Thus far, I haven’t been able to find any information either on what it combined with or implications for symptom severity. Right now, XDV.1 is estimated to represent little more than 3% of new US infections, but that number is 287% higher than six weeks ago. While the currently-dominant JN.1 family still accounts for more than 90% of all new cases, every family of COVID strains is sooner or later replaced by a novel strain better equipped to evade human immunity, and XDV.1 is the first such challenger to thus far emerge. Within the JN.1 family, with a 25% share, KP.3 has just displaced KP.2 for the top spot.